NEW Wilsons Research & Valuation Report

Wilsons Equity Research has released its latest research and valuation report on Anatara Lifesciences (ANR). The report maintained a BUY rating and a price target of $1.66 per share.

Still have our nose in this little trough

Please open the attached PDF to view the report.